{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T10:59:56Z","timestamp":1783594796517,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.bbapap.2016.07.011","type":"journal-article","created":{"date-parts":[[2016,7,30]],"date-time":"2016-07-30T20:58:05Z","timestamp":1469912285000},"page":"1428-1435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Amblyomin-X having a Kunitz-type homologous domain, is a noncompetitive inhibitor of FXa and induces anticoagulation in vitro and in vivo"],"prefix":"10.1016","volume":"1864","author":[{"given":"Vania G.","family":"Branco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miryam P.","family":"Alvarez-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana M.","family":"Sciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia A.","family":"de Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo K.","family":"Iwai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solange M.T.","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Chudzinski-Tavassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbapap.2016.07.011_bb0005","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.dci.2012.10.005","article-title":"Structure and function of invertebrate Kunitz serine protease inhibitors","volume":"39","author":"Ranasinghe","year":"2013","journal-title":"Dev. Comp. Immunol."},{"issue":"2","key":"10.1016\/j.bbapap.2016.07.011_bb0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0022-2836(75)90389-7","article-title":"The two-disulphide intermediates and the folding pathway of reduced pancreatic trypsin inhibitor","volume":"95","author":"Creighton","year":"1975","journal-title":"J. Mol. Biol."},{"issue":"4","key":"10.1016\/j.bbapap.2016.07.011_bb0015","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1006\/jmbi.1998.2437","article-title":"Evolutionary trace analysis of the Kunitz\/BPTI family of proteins: Functional divergence may have been based on conformational adjustment","volume":"285","author":"Pritchard","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbapap.2016.07.011_bb0020","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.bi.49.070180.003113","article-title":"Protein inhibitors of proteinases","volume":"49","author":"Laskowski","year":"1980","journal-title":"Annu. Rev. Biochem."},{"issue":"Database issue","key":"10.1016\/j.bbapap.2016.07.011_bb0025","doi-asserted-by":"crossref","first-page":"D227","DOI":"10.1093\/nar\/gkp971","article-title":"MEROPS: The peptidase database","volume":"38","author":"Rawlings","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"Pt 3","key":"10.1016\/j.bbapap.2016.07.011_bb0030","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1042\/bj20031825","article-title":"Evolutionary families of peptidase inhibitors","volume":"378","author":"Rawlings","year":"2004","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.bbapap.2016.07.011_bb0035","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/ATVBAHA.107.141606","article-title":"The haemostatic role of tissue factor pathway inhibitor","volume":"28","author":"Crawley","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.bbapap.2016.07.011_bb0040","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1055\/s-2007-991531","article-title":"The role of tissue factor pathway inhibitor in tumor growth and metastasis","volume":"33","author":"Amirkhosravi","year":"2007","journal-title":"Semin. Thromb. Hemost."},{"issue":"11","key":"10.1016\/j.bbapap.2016.07.011_bb0045","first-page":"2997","article-title":"Tissue factor\/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism","volume":"63","author":"Hembrough","year":"2003","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bbapap.2016.07.011_bb0050","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1160\/TH09-04-0221","article-title":"Molecular diversity of anticoagulants from haematophagous animals","volume":"102","author":"Koh","year":"2009","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.bbapap.2016.07.011_bb0055","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.abb.2009.10.009","article-title":"A new factor Xa inhibitor from Amblyomma cajennense with a unique domain composition","volume":"493","author":"Batista","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.bbapap.2016.07.011_bb0060","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.biopha.2011.11.015","article-title":"Pro-apoptotic effects of Amblyomin-X in murine renal cell carcinoma \u2018in vitro","volume":"66","author":"Akagi","year":"2012","journal-title":"Biomed. Pharmacother. Biom\u00e9d. Pharmacoth\u00e9rapie"},{"issue":"7","key":"10.1016\/j.bbapap.2016.07.011_bb0065","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.toxicon.2010.04.019","article-title":"A new tick Kunitz type inhibitor, Amblyomin-X, induces tumor cell death by modulating genes related to the cell cycle and targeting the ubiquitin-proteasome system","volume":"56","author":"Chudzinski-Tavassi","year":"2010","journal-title":"Toxicon Off. J. Int. Soc. Toxinology"},{"issue":"3","key":"10.1016\/j.bbapap.2016.07.011_bb0070","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.toxicon.2012.04.349","article-title":"Actions of the Kunitz-type serine protease inhibitor Amblyomin-X on VEGF-A-induced angiogenesis","volume":"60","author":"Drewes","year":"2012","journal-title":"Toxicon Off. J. Int. Soc. Toxinology"},{"key":"10.1016\/j.bbapap.2016.07.011_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxicon.2015.04.002","article-title":"Post-transcriptional control of Amblyomin-X on secretion of vascular endothelial growth factor and expression of adhesion molecules in endothelial cells","volume":"101","author":"Drewes","year":"2015","journal-title":"Toxicon Off. J. Int. Soc. Toxinology"},{"issue":"3","key":"10.1016\/j.bbapap.2016.07.011_bb0080","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10637-012-9871-1","article-title":"A novel proteasome inhibitor acting in mitochondrial dysfunction, ER stress and ROS production","volume":"31","author":"Maria","year":"2013","journal-title":"Investig. New Drugs"},{"issue":"12","key":"10.1016\/j.bbapap.2016.07.011_bb0085","doi-asserted-by":"crossref","first-page":"e111907","DOI":"10.1371\/journal.pone.0111907","article-title":"Dynein function and protein clearance changes in tumor cells induced by a Kunitz-type molecule, Amblyomin-X","volume":"9","author":"Pacheco","year":"2014","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.bbapap.2016.07.011_bb0090","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.yexcr.2015.12.016","article-title":"Specific role of cytoplasmic dynein in the mechanism of action of an antitumor molecule, Amblyomin-X","volume":"340","author":"Pacheco","year":"2016","journal-title":"Exp. Cell Res."},{"issue":"3","key":"10.1016\/j.bbapap.2016.07.011_bb0095","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.biopha.2012.11.009","article-title":"A Kunitz-type FXa inhibitor affects tumor progression, hypercoagulable state and triggers apoptosis","volume":"67","author":"Ventura","year":"2013","journal-title":"Biomed. Pharmacother. Biom\u00e9d. Pharmacoth\u00e9rapie"},{"issue":"3","key":"10.1016\/j.bbapap.2016.07.011_bb0100","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.critrevonc.2003.10.003","article-title":"The prothrombotic state in cancer: Pathogenic mechanisms","volume":"50","author":"De Cicco","year":"2004","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"3\u20134","key":"10.1016\/j.bbapap.2016.07.011_bb0105","first-page":"122","article-title":"Overview of the postulated mechanisms linking cancer and thrombosis","volume":"36","author":"ten Cate","year":"2008","journal-title":"Pathophysiol. Haemost. Thromb."},{"issue":"12","key":"10.1016\/j.bbapap.2016.07.011_bb0110","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1021\/bi00631a035","article-title":"A simple method for the preparation of homogeneous phospholipid vesicles","volume":"16","author":"Barenholz","year":"1977","journal-title":"Biochemistry (Mosc)"},{"issue":"27","key":"10.1016\/j.bbapap.2016.07.011_bb0115","doi-asserted-by":"crossref","first-page":"8284","DOI":"10.1073\/pnas.1504229112","article-title":"Discovery of an intrinsic tenase complex inhibitor: Pure nonasaccharide from fucosylated glycosaminoglycan","volume":"112","author":"Zhao","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.bbapap.2016.07.011_bb0120","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/01.ATV.18.3.458","article-title":"Plasma lipoproteins support prothrombinase and other procoagulant enzymatic complexes","volume":"18","author":"Moyer","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbapap.2016.07.011_bb0125","doi-asserted-by":"crossref","DOI":"10.1111\/jth.13041","article-title":"Pro-coagulant and pro-inflammatory effects of red blood cells on LPS-stimulated monocytes","author":"\u00d8sterud","year":"2015","journal-title":"J. Thromb. Haemost"},{"issue":"3","key":"10.1016\/j.bbapap.2016.07.011_bb0130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/092986611794578297","article-title":"Structural characterization of metalloprotease vibriolysin of cholera pathogen vibrio cholerae","volume":"18","author":"Iqbal","year":"2011","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.bbapap.2016.07.011_bb0135","series-title":"Allosteric Inhibition of Factor XIa. Sulfated Non-Saccharide Glycosaminoglycan Mimetics as Promising Anticoagulants","author":"Al-Horani","year":"2015"},{"key":"10.1016\/j.bbapap.2016.07.011_bb0140","first-page":"920942","article-title":"Purification and characterization of BmooAi: A new toxin from Bothrops moojeni snake venom that inhibits platelet aggregation","volume":"2014","author":"de Queiroz","year":"2014","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.bbapap.2016.07.011_bb0145","series-title":"Characteristics and Risk Factors of Cancer Associated Venous Thromboembolism","author":"Faiz","year":"2015"},{"key":"10.1016\/j.bbapap.2016.07.011_bb0150","series-title":"Amblyomin-X Induces ER Stress, Mitochondrial Dysfunction, and Caspase Activation in Human Melanoma and Pancreatic Tumor Cell","author":"Morais","year":"2016"},{"issue":"6","key":"10.1016\/j.bbapap.2016.07.011_bb0155","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.3390\/md11062069","article-title":"Protease inhibitors from marine venomous animals and their counterparts in terrestrial venomous animals","volume":"11","author":"Mour\u00e3o","year":"2013","journal-title":"Mar. Drugs"},{"issue":"5","key":"10.1016\/j.bbapap.2016.07.011_bb0160","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2174\/0929866520666131210115334","article-title":"Structural findings and molecular modeling approach of a TFPI-like inhibitor","volume":"21","author":"Pasqualoto","year":"2014","journal-title":"Protein Pept. Lett."},{"issue":"3","key":"10.1016\/j.bbapap.2016.07.011_bb0165","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0049-3848(98)00205-9","article-title":"Inhibitory properties of human recombinant Arg24\u2192Gln type-2 tissue factor pathway inhibitor (R24Q TFPI-2)","volume":"94","author":"Kamei","year":"1999","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bbapap.2016.07.011_bb0170","doi-asserted-by":"crossref","DOI":"10.1160\/TH05-07-0509","article-title":"Structure, function and biology of tissue factor pathway inhibitor-2","author":"Chand","year":"2005","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.bbapap.2016.07.011_bb0175","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1160\/TH11-12-0902","article-title":"The Kunitz 1 and Kunitz 3 domains of tissue factor pathway inhibitor are required for efficient inhibition of factor Xa","volume":"108","author":"Peraramelli","year":"2012","journal-title":"Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.bbapap.2016.07.011_bb0180","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1182\/blood-2001-12-0237","article-title":"Ixolaris, a novel recombinant tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick, Ixodes scapularis: Identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa\/tissue factor complex","volume":"99","author":"Francischetti","year":"2002","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bbapap.2016.07.011_bb0185","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1160\/TH03-11-0715","article-title":"Penthalaris, a novel recombinant five-Kunitz tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick vector of Lyme disease, Ixodes scapularis","volume":"91","author":"Francischetti","year":"2004","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.bbapap.2016.07.011_bb0190","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1160\/TH15-04-0354","article-title":"Role of exosite binding modulators in the inhibition of Fxa by TFPI","volume":"115","author":"Peraramelli","year":"2015","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bbapap.2016.07.011_bb0195","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2741\/3926","article-title":"Tissue factor pathway inhibitor: Structure-function","volume":"17","author":"Broze","year":"2012","journal-title":"Front. Biosci. Landmark Ed."},{"issue":"7","key":"10.1016\/j.bbapap.2016.07.011_bb0200","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1074\/jbc.M112.414235","article-title":"Disulfide scrambling describes the oligomer formation of superoxide dismutase (SOD1) proteins in the familial form of amyotrophic lateral sclerosis","volume":"288","author":"Toichi","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bbapap.2016.07.011_bb0205","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1074\/mcp.M113.034009","article-title":"Matching cross-linked peptide spectra: Only as good as the worse identification","volume":"13","author":"Trnka","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"issue":"40","key":"10.1016\/j.bbapap.2016.07.011_bb0210","doi-asserted-by":"crossref","first-page":"15334","DOI":"10.1073\/pnas.0802699105","article-title":"Crystal structure of an extensively simplified variant of bovine pancreatic trypsin inhibitor in which over one-third of the residues are alanines","volume":"105","author":"Islam","year":"2008","journal-title":"Proc. Natl. Acad. Sci."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963916301479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963916301479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T20:04:16Z","timestamp":1568232256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570963916301479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1570963916301479"],"URL":"https:\/\/doi.org\/10.1016\/j.bbapap.2016.07.011","relation":{},"ISSN":["1570-9639"],"issn-type":[{"value":"1570-9639","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amblyomin-X having a Kunitz-type homologous domain, is a noncompetitive inhibitor of FXa and induces anticoagulation in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbapap.2016.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}